|
|
| NDC Number | Brand Name | Generic Name | Labeler | Dosage Form | DEA Schedule | Marketing Start Date |
|---|---|---|---|---|---|---|
| 69604-204 | Anthim | obiltoxaximab | Elusys Therapeutics, Inc. | SOLUTION | 2016-03-18 | |
| 71655-103 | Raxibacumab | raxibacumab | Emergent Manufacturing Operations Baltimore LLC | INJECTION | 2012-12-14 |
Loading full table content...